SI1758609T1 - Cepivo proti HPV16 in HPV18 in vsaj še enemu tipu HPV, izbranemu izmed HPV 31, 45 ali 52 - Google Patents

Cepivo proti HPV16 in HPV18 in vsaj še enemu tipu HPV, izbranemu izmed HPV 31, 45 ali 52

Info

Publication number
SI1758609T1
SI1758609T1 SI200531633T SI200531633T SI1758609T1 SI 1758609 T1 SI1758609 T1 SI 1758609T1 SI 200531633 T SI200531633 T SI 200531633T SI 200531633 T SI200531633 T SI 200531633T SI 1758609 T1 SI1758609 T1 SI 1758609T1
Authority
SI
Slovenia
Prior art keywords
hpv
hpv18
type selected
vaccine against
another
Prior art date
Application number
SI200531633T
Other languages
English (en)
Slovenian (sl)
Inventor
Serge GlaxoSmithKline Biologicals S.A. DEBRUS
Marie-Therese Martin
Robert John GlaxoSmithKline STEPHEN
Jean GlaxoSmithKline Biologicals S.A. STEPHENNE
Martine Anne Cecile Wettendorff
Original Assignee
Glaxosmithkline Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/114,301 external-priority patent/US20050287161A1/en
Application filed by Glaxosmithkline Biologicals S.A. filed Critical Glaxosmithkline Biologicals S.A.
Priority claimed from EP05757953A external-priority patent/EP1758609B1/en
Publication of SI1758609T1 publication Critical patent/SI1758609T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/12Keratolytics, e.g. wart or anti-corn preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5258Virus-like particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55572Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/20011Papillomaviridae
    • C12N2710/20022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/20011Papillomaviridae
    • C12N2710/20034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
SI200531633T 2004-06-16 2005-06-14 Cepivo proti HPV16 in HPV18 in vsaj še enemu tipu HPV, izbranemu izmed HPV 31, 45 ali 52 SI1758609T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB0413510.9A GB0413510D0 (en) 2004-06-16 2004-06-16 Vaccine
US11/114,301 US20050287161A1 (en) 2002-12-20 2005-04-26 Vaccine
EP05757953A EP1758609B1 (en) 2004-06-16 2005-06-14 Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52
PCT/EP2005/006461 WO2005123125A1 (en) 2004-06-16 2005-06-14 Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52

Publications (1)

Publication Number Publication Date
SI1758609T1 true SI1758609T1 (sl) 2013-01-31

Family

ID=32750044

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200531633T SI1758609T1 (sl) 2004-06-16 2005-06-14 Cepivo proti HPV16 in HPV18 in vsaj še enemu tipu HPV, izbranemu izmed HPV 31, 45 ali 52

Country Status (15)

Country Link
JP (1) JP2012102132A (enrdf_load_html_response)
KR (1) KR101359943B1 (enrdf_load_html_response)
CN (1) CN1976718B (enrdf_load_html_response)
CY (1) CY1113830T1 (enrdf_load_html_response)
DK (1) DK1758609T3 (enrdf_load_html_response)
ES (1) ES2394448T3 (enrdf_load_html_response)
GB (1) GB0413510D0 (enrdf_load_html_response)
HR (1) HRP20120930T1 (enrdf_load_html_response)
HU (3) HUS1500059I1 (enrdf_load_html_response)
LT (1) LTC1758609I2 (enrdf_load_html_response)
NL (3) NL300774I2 (enrdf_load_html_response)
PT (1) PT1758609E (enrdf_load_html_response)
SI (1) SI1758609T1 (enrdf_load_html_response)
TW (1) TW200612983A (enrdf_load_html_response)
ZA (1) ZA200610057B (enrdf_load_html_response)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102458440A (zh) * 2009-04-10 2012-05-16 约翰·霍普金斯大学 作为广谱人类乳头状瘤病毒(hpv)疫苗的乳头状瘤病毒样颗粒(vlp)
JP5964298B2 (ja) * 2010-07-15 2016-08-03 ブリティッシュ コロンビア キャンサー エージェンシー ブランチ ヒトパピローマウイルスe7抗原組成物およびその使用
CN107188966B (zh) 2016-03-15 2020-03-31 中国医学科学院基础医学研究所 一种乳头瘤病毒嵌合蛋白及其用途
CN114539365B (zh) * 2020-11-26 2023-12-01 中国医学科学院基础医学研究所 一种改造的人乳头瘤病毒52型l1蛋白及其用途
CN114716560B (zh) 2021-01-04 2024-02-02 中国医学科学院基础医学研究所 一种人乳头瘤病毒18型嵌合蛋白及其用途
CN114716561B (zh) 2021-01-04 2024-03-12 中国医学科学院基础医学研究所 一种人乳头瘤病毒31型嵌合蛋白及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9921146D0 (en) * 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
GB9921147D0 (en) * 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
GB0110431D0 (en) * 2001-04-27 2001-06-20 Glaxosmithkline Biolog Sa Novel compounds
GB0206360D0 (en) * 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens
GB0206359D0 (en) * 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens

Also Published As

Publication number Publication date
LTC1758609I2 (lt) 2017-05-10
HUS1500059I1 (hu) 2017-10-30
NL300774I1 (enrdf_load_html_response) 2015-12-29
NL300773I1 (enrdf_load_html_response) 2015-12-29
NL300774I2 (enrdf_load_html_response) 2015-12-29
CY1113830T1 (el) 2016-06-22
HUS1500060I1 (hu) 2017-10-30
HRP20120930T1 (hr) 2012-12-31
DK1758609T3 (da) 2012-12-10
GB0413510D0 (en) 2004-07-21
ES2394448T3 (es) 2013-01-31
KR20120123617A (ko) 2012-11-08
JP2012102132A (ja) 2012-05-31
NL300771I1 (enrdf_load_html_response) 2015-12-29
TW200612983A (en) 2006-05-01
NL300773I2 (enrdf_load_html_response) 2015-12-29
ZA200610057B (en) 2008-02-27
KR101359943B1 (ko) 2014-02-10
HUS1500061I1 (hu) 2016-01-28
PT1758609E (pt) 2012-12-21
CN1976718B (zh) 2012-10-10
CN1976718A (zh) 2007-06-06
NL300771I2 (enrdf_load_html_response) 2015-12-29

Similar Documents

Publication Publication Date Title
HUS1500060I1 (hu) A HPV16 és HPV18 és a HPV 31, 45 vagy 52 közül legalább egy másik HPV típus elleni vakcina
IL190775A (en) Influenza virus-like particles, vaccines containing them and their uses
IL179138A0 (en) Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31,45, or 52
PT1572233E (pt) Utilização de hpv16 e hpv18 como vacina contra um ou mais de tipos de hpv oncogénicos 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68
EP1784163A4 (en) NANOEMULSION, USE THEREOF AND PROCESS FOR PREPARING THE SAME
IL178160A0 (en) Cellular permissivity factor for viruses, and uses thereof
WO2007106351A3 (en) Porous silicon materials and devices
AU2003271215A8 (en) Vector for anti-hpv vaccine and transformed microorganism by the vector
USD502767S1 (en) Heater fan
AU2003290012A1 (en) L2-peptide of the human papillomavirus associated with virus-like particles
IL177903A (en) Vaccine for Infectious Stock Disease Virus and its Use
HK1103634A (en) Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52
SI1572233T1 (sl) Uporaba HPV16 in HPV18 kot cepivo proti enemu ali več onkogenih HPV tipa 31,33,35,39,45,51,52,56,58,59,66,68
AU2002236065A1 (en) Papillomavirus vaccines
CY2015049I1 (el) Εμβολιο εναντι hpv16 και hpv18 και τουλαχιστον ενος αλλου τυπου hpv ο οποιος επιλεγεται απο hpv 31,45 ή 52
Moktan Book of oral recitations and moral teachings
AU2001266534A1 (en) Papillomavirus vaccine
Rowe It's the overall amount, silly
Viravan The strategic role of distribution channel toward firm's success
Bullis Residents and Faculty, Eastman Dental Center, 2004
Seppa Stroke Stopper
AU2003292136A1 (en) Vaccines against viruses with cationic substances as adjuvants
AU2004903497A0 (en) Hepatitis B virus polymerase
HK1125388A (en) Hpv antigens, vaccine compositions, and related methods
GB0100430D0 (en) Virus strains